Ionis Pharmaceuticals Files 8-K on Director Changes and Compensation
Ticker: IONS · Form: 8-K · Filed: Jun 12, 2025 · CIK: 874015
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: IONS
TL;DR
IONIS filed an 8-K: board changes and exec comp updates. Watch for governance shifts.
AI Summary
On June 12, 2025, Ionis Pharmaceuticals, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing includes information regarding the election of new directors and potential adjustments to compensatory plans for its key officers.
Why It Matters
Changes in a company's board of directors and executive compensation can signal shifts in strategic direction or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is routine and primarily concerns corporate governance and executive compensation, with no immediate financial or operational risks disclosed.
Key Players & Entities
- IONIS PHARMACEUTICALS, INC. (company) — Registrant
- June 12, 2025 (date) — Date of report
- 2855 Gazelle Court Carlsbad , CA 92010 (address) — Principal Executive Offices
- 760-931-9200 (phone_number) — Business phone
FAQ
What specific changes were made to the board of directors?
The filing indicates the "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of disclosure, suggesting changes to the board composition.
What is the nature of the compensatory arrangements mentioned?
The filing lists "Compensatory Arrangements of Certain Officers" as a disclosed item, implying updates or new information regarding executive pay.
When was the earliest event reported in this 8-K?
The earliest event reported is dated June 12, 2025.
What is Ionis Pharmaceuticals' state of incorporation?
Ionis Pharmaceuticals, Inc. is incorporated in Delaware.
What is the SIC code for Ionis Pharmaceuticals?
The Standard Industrial Classification (SIC) code for Ionis Pharmaceuticals is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 12, 2025 regarding IONIS PHARMACEUTICALS INC (IONS).